Table 2.
Results of p16 Detection by Immunocytochemistry Compared with Cytological Assessment According to Histological Diagnosis.
| Histology | n | Cytology | p16 | ||
|---|---|---|---|---|---|
| Diagnosis | n | + | — | ||
| Cancer | 13 | Cancer | 2 | 2 | 0 |
| HSIL | 8 | 8 | 0 | ||
| ASC-H | 3 | 3 | 0 | ||
| HSIL | 112 | HSIL | 35 | 35 | 0 |
| ASC-H | 41 | 41 | 0 | ||
| LSIL | 9 | 9 | 0 | ||
| ASC-US | 11 | 10 | 1 | ||
| NILM | 16 | 12 | 4 | ||
| LSIL | 45 | ASC-H | 2 | 1 | 1 |
| LSIL | 22 | 6 | 16 | ||
| ASC-US | 12 | 1 | 11 | ||
| NILM | 9 | 5 | 4 | ||
| Benign | 108 | HSIL | 1 | 0 | 1 |
| ASC-H | 8 | 1 | 7 | ||
| ASC-US | 2 | 0 | 2 | ||
| NILM | 97 | 4 | 93 | ||
| Total | 278 | 278 | 138 | 140 | |
Carcinoma, invasive carcinoma; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; NILM, negative for intraepithelial lesion or malignancy; Benign, no intraepithelial lesion.